» Articles » PMID: 24114568

Breast Cancer Statistics, 2013

Overview
Publisher Wiley
Specialty Oncology
Date 2013 Oct 12
PMID 24114568
Citations 990
Authors
Affiliations
Soon will be listed here.
Abstract

In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur among US women in 2013. One in 8 women in the United States will develop breast cancer in her lifetime. Breast cancer incidence rates increased slightly among African American women; decreased among Hispanic women; and were stable among whites, Asian Americans/Pacific Islanders, and American Indians/Alaska Natives from 2006 to 2010. Historically, white women have had the highest breast cancer incidence rates among women aged 40 years and older; however, incidence rates are converging among white and African American women, particularly among women aged 50 years to 59 years. Incidence rates increased for estrogen receptor-positive breast cancers in the youngest white women, Hispanic women aged 60 years to 69 years, and all but the oldest African American women. In contrast, estrogen receptor-negative breast cancers declined among most age and racial/ethnic groups. These divergent trends may reflect etiologic heterogeneity and the differing effects of some factors, such as obesity and parity, on risk by tumor subtype. Since 1990, breast cancer death rates have dropped by 34% and this decrease was evident in all racial/ethnic groups except American Indians/Alaska Natives. Nevertheless, survival disparities persist by race/ethnicity, with African American women having the poorest breast cancer survival of any racial/ethnic group. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population.

Citing Articles

Breast cancer awareness, knowledge and self-screening intention among females in Northern Border of Saudi Arabia, Arar City.

Alanazi W, Mohamed G, Alosaimi N, Alosaimi L BMC Public Health. 2025; 25(1):964.

PMID: 40069709 PMC: 11899163. DOI: 10.1186/s12889-025-22092-w.


The screening value of mammography for breast cancer: an overview of 28 systematic reviews with evidence mapping.

Shi J, Li J, Gao Y, Chen W, Zhao L, Li N J Cancer Res Clin Oncol. 2025; 151(3):102.

PMID: 40047905 PMC: 11885354. DOI: 10.1007/s00432-025-06122-z.


Association of social support and religiosity with survival among women with breast cancer in a low-income population in the Southeastern United States.

Fisa R, Mwala K, DeMoulin D, Kayamba V, Shrubsole M, Shu X BMC Public Health. 2025; 25(1):708.

PMID: 39979978 PMC: 11844068. DOI: 10.1186/s12889-025-21908-z.


Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final Analysis.

Loap P, Uakkas A, Allali S, Bouziane J, Fourquet A, Kirova Y Cancers (Basel). 2025; 17(3).

PMID: 39941910 PMC: 11817461. DOI: 10.3390/cancers17030544.


Nanoparticles Codelivering mRNA and SiRNA for Simultaneous Restoration and Silencing of Gene/Protein Expression In Vitro and In Vivo.

Manturthi S, El-Sahli S, Bo Y, Durocher E, Kirkby M, Popatia A ACS Nanosci Au. 2024; 4(6):416-425.

PMID: 39713729 PMC: 11659891. DOI: 10.1021/acsnanoscienceau.4c00040.